Senators Call for 15 Years of Marketing Exclusivity for Some New Drugs
Published 12 December 2014
Two US senators have proposed new legislation that would grant an unprecedented 15 years of marketing exclusivity to certain types of pharmaceutical and biopharmaceutical products.
Categories: News, US, CDER, Biologics and biotechnology, Drugs
Tags: MODDERN Cures Act, Marketing Exclusivity, Senate, Congress, Bill, Legislation, Dormant Therapies Act